FDAClass IIDecember 8, 2021

Total Thyroxine recall

Total Thyroxine (T4) ELISA; REF EIA-1781

Why was Total Thyroxine recalled?

Firm has identified two lots of product that do not meet product shelf life, resulting in failed Controls. The clinical impact may be a delay in diagnosis and a consumption of patient samples.

What should I do if I have this product?

The recall is ongoing. Follow the firm and FDA instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

lot#: RN-60923 expiration date 12/31/2021; RN-60831 expiration date 12/31/2021

Product
Total Thyroxine (T4) ELISA; REF EIA-1781
Recalling firm
DRG International, Inc.
Quantity
314 total (270 US)
Distribution
Domestic: NY; International: TZ, VN, BD, CO, TT, YE, BO, DE, SV, GE, PY, TG, RU/UA, NI, DO, NG, EG & CM
Recall date
December 8, 2021
Classification
Class II
Status
Ongoing
Agency
FDA (device)
Open FDA enforcement record Latest recalls